Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > LMNL to Face Investors

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon Oct 20, 2019 9:54am

57 Views

Post# 30248511

RE:LMNL to Face Investors

Another investor conference, LOL

The last Wainwright conference, the person introducing them didn't even get the name right.

Introducing "PROMETRIC". I am sure that was why the audience of two didn't buy the stock.